tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Posts Tagged 'Breast Cancer'

PharmaCyte Biotech’s Cancer Treatment Shows “Complete Tumor Remission” in Published Preclinical Study

PharmaCyte Biotech’s Cancer Treatment Shows “Complete Tumor Remission” in Published Preclinical Study

Written by Ι Stock Market Media — June 3, 2015

NEW YORK, NY — PharmaCyte Biotech’s (OTCQB: PMCB) signature live-cell encapsulation technology, Cell-in-a-Box®, was the star of the show in a recently released corporate video by the company. In that video, PharmaCyte revealed that its cancer treatment of Cell-in-a-Box® plus low doses of the anticancer drug ifosfamide was able to produce “complete tumor remission in all animals” that received the treatment on days 2-6 of a previously published preclinical study.

It was a study ...

Read More →
0

PharmaCyte Biotech Equity Research by Stonegate Capital Partners

PharmaCyte Biotech Equity Research by Stonegate Capital Partners

On May 28, 2015, Stonegate Capital Partners released an extensive Equity Research Report on PharmaCyte Biotech, Inc.  The firm’s reports are issued to targeted funds, and institutional investors also have access to Stonegate’s research from a variety of services including Bloomberg, Thomson Reuters, Zach’s, Capital IQ, The Markets, Morningstar and FactSet among others. Stonegate has the ability to actively track the institutional investors who access their research.

Click to View Stonegate Capital Partners Equity Research on PharmaCyte ...

Read More →
0

Nuvilex Announces Name Change to PharmaCyte Biotech

Nuvilex Announces Name Change to PharmaCyte Biotech

Company’s Shares Will Trade Under New Ticker Symbol PHCB

SILVER SPRING, MD., Jan. 7, 2015 — Nuvilex, Inc. (NVLX) today announced that the Company has changed its name to PharmaCyte Biotech, Inc. Shares in PharmaCyte Biotech will trade under the new ticker symbol “PHCB” on the OTCQB electronic platform. The new symbol is expected to become effective at the open of the market on January 8, 2014. The name change ...

Read More →
0

Nuvilex, Inc. Engaged in “Cutting Edge” Cannabis Preclinical Studies Using Model Compounds with Cell-in-a-Box

Written by Ι Stock Market Media Group Staff — October 29, 2014

New York, NY – Nuvilex, Inc. (OTCQB: NVLX) isn’t letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its research.  The company is currently engaged in preclinical studies at the University of Northern Colorado (UNC) targeting Cannabis-based cancer treatments using Nuvilex’s Cell-in-a-Box® cellulose-based live cell encapsulation technology. 

While waiting for a Schedule 1 license from the DEA in order to conduct research using marijuana, Dr. ...

Read More →
0

Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly

Chicago Investment Firm Assumes $27 Million Risk to Help Nuvilex Unseat Celgene and Eli Lilly

Written by ι Stock Market Media Group Staff — February 24, 2014

Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be viewed as a $27 million “pot of money” to advance the company’s late-phase pancreatic cancer clinical trials.  Notice we said restricted shares, that’s right, LPC has put a great deal of its money on the line with a number of built in protections for Nuvilex.  ...

Read More →
0

Nuvilex, Inc. Cell Encapsulation Could Mimic Combination Chemotherapy

Nuvilex, Inc. Cell Encapsulation Could Mimic Combination Chemotherapy

Written by ι Stock Market Media Group Staff — May 15, 2013

Nuvilex, Inc. (OTCQB: NVLX) has had its living cell encapsulation or “Cell-in-a-Box” technology tested again and again, and each time it has proven it can do exactly what it’s intended to do.  To date, the proprietary technology has more than impressed and continuously returns remarkable data after each study.  In a study not yet discussed, “Cell-in-a-Box” was used to enclose cells that activate more than one anticancer drug simultaneously.  This is ...

Read More →
0
ContactUs.com